Trials
Search / Trial NCT06424197

Colorectal Cancer Screening Intervention Study

Launched by OAKLAND UNIVERSITY · May 16, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Active, not recruiting

Keywords

Colorectcal Cancer Screening Targeted Message Intervention

ClinConnect Summary

Colorectal cancer (CRC) is one of the leading causes of cancer mortality in the United States, and African Americans (AfAms) still fare worse in CRC incidence and mortality compared to European Americans (EuAms).Interventions to increase CRC screening rates among AfAms are instrumental to address the disparities in CRC incidence and mortality. Despite literature indicating that AfAms' fears (e.g., of colonoscopy procedures or cancer diagnosis) serve as barriers to CRC screening, no interventions have used theory-guided methods to directly target fear-based beliefs. Additionally, no research...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • African American Overdue to colorectal cancer screening Has primary care physician Not at high risk for colorectal cancer
  • Exclusion Criteria:
  • • Not meeting inclusion criteria

Trial Officials

Mark Manning, PhD

Principal Investigator

Oakland University

About Oakland University

Oakland University is a distinguished clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies. Based in Rochester, Michigan, the university fosters a collaborative environment that integrates academic rigor with practical application, engaging multidisciplinary teams of researchers, healthcare professionals, and students. Committed to ethical standards and regulatory compliance, Oakland University focuses on a diverse range of clinical trials that address pressing health challenges, aiming to contribute valuable insights to the scientific community and enhance therapeutic options for patients.

Locations

Rochester, Michigan, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0